CompletedNCT05972044
Solriamfetol safety and efficacy study for ADHD
About this title
Read the official source —Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- Encino and 41 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: July 6, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 516
- Sponsor
- Axsome Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05972044
- Official title
Show the full official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults With ADHD.
Get this study by email
Recruitment & locations
CompletedEncino · Garden Grove · Newport Beach
37 more locations
- Riverside
- Santa Ana
- Sherman Oaks
- Torrance
- Walnut Creek
- Colorado Springs
- Clermont
- Doral
- Gainesville
- Jacksonville
- Lauderhill
- Miami Lakes
- Orlando
- Marietta
- Overland Park
- Boston
- Saint Charles
- Lincoln
- Las Vegas
- Berlin
- Cherry Hill
- Princeton
- Mount Kisco
- New York
- Raleigh
- Cincinnati
- Kettering
- Oklahoma City
- Media
- North Charleston
- Memphis
- Austin
- Bellaire
- Dallas
- San Antonio
- Draper
- Everett
Questions about this study
Who is behind this study?
The study sponsor is Axsome Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including Solriamfetol 150 mg, Solriamfetol 300 mg and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
